Dr. Campopiano has 20 years of experience in primary care medicine and addiction medicine including delivering care in hospitals, nursing homes, her own private practice, FQHC look-alikes, and for incarcerated patients. She has trained student health professionals, residents and health professionals in primary care, obstetrics, behavioral health, integration of care and addiction treatment including the use of pharmacotherapy for opioid and alcohol use disorders, syringe services and overdose prevention. She helped develop, implement, and evaluate an SBIRT curriculum for student health professionals in cooperation with the Pennsylvania Department of Health. As Senior Medical Advisor for SAMHSA, she developed seminal federal documents on opioid overdose prevention, pharmacotherapy for opioid use disorder, and substance-exposed pregnancy. She convened or chaired meetings on addiction and behavioral health involving stakeholders from across federal government (HHS, DOJ, ONDCP), research, clinical practice, and people with experience and oversaw regulation development and enforcement.Â Her current work at JBS includes providing medical and technical expertise to support RCORP and contributing to the evaluation design and implementation for HRSAâ€™s MCHB. Dr. Campopiano received her medical degree from the University of Pittsburgh School of Medicine and completed her medical residency at University of Pittsburgh Medical Centerâ€™s Shadyside Family Practice. She is board certified in both Family Medicine and Addiction Medicine.
Melinda Campopiano MD
Senior Medical Advisor
“Sometimes, women with OUD are encouraged to seek treatment while theyâ€™re pregnant and then encouraged to get off of medication-assisted treatment (MAT) after theyâ€™ve given birth. What happens is that they relapse. Breastfeeding among opiate-dependent women who are stable on MAT is the better course of action, because it can improve bonding with the baby.”